[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351503-105":59,"doc-detail-351503-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multicentric-validation-of-a-complete-blood-countbased-model-for-breast-cancer-risk-stratification-in-women-age-40-49-years","Multicentric Validation of a Complete Blood Count–Based Model for Breast Cancer Risk Stratification in Women Age 40-49 Years","","Breast cancer screening guideline updates have expanded eligibility to women aged 40–49, but risk stratification remains difficult. This retrospective multicenter study assessed an existing complete blood count (CBC)–based breast cancer risk model, originally built for ages 40–70, in a Brazilian cohort. CBCs from 239,089 women were analyzed using ridge regression with age, neutrophil-to-lymphocyte ratio (NLR), and RBC. Performance was evaluated by AUC, sensitivity, and specificity using leave-one-group-out cross-validation across five clinical settings, showing best discrimination when CBCs were collected within 3 months before diagnosis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multicentric-validation-of-a-complete-blood-countbased-model-for-breast-cancer-risk-stratification-in-women-age-40-49-years/351503/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multicentric-validation-of-a-complete-blood-countbased-model-for-breast-cancer-risk-stratification-in-women-age-40-49-years/351503.png","ImageObject",300,407,{"name":92,"@type":93},"Sarah ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study’s main objective for women aged 40–49?","Question",{"text":112,"@type":113},"To evaluate whether routinely collected complete blood count (CBC) data can opportunistically stratify breast cancer risk in women aged 40–49, where access to systematic screening is limited.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were CBC data prepared and compared across clinical timelines?",{"text":117,"@type":113},"CBCs were stratified by timing relative to breast diagnostic procedures: same day, 1–90 days prior, and 91–180 days prior, and model performance was assessed with AUC, sensitivity, and specificity.",{"name":119,"@type":110,"acceptedAnswer":120},"What factors affected model performance as diagnosis approached?",{"text":121,"@type":113},"Discrimination was stable when CBCs were collected within 3 months of diagnosis and declined for the 91–180-day interval; the neutrophil-to-lymphocyte ratio increased closer to diagnosis, driven mainly by neutrophilia.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351503,1790787545,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962085320529,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Original Reports | Artiﬁcial Intelligence  \nMulticentric Validation of a Complete Blood Count–Based Model for Breast Cancer Risk Stratiﬁcation in Women Age  \n40-49 Years  \nDaniella Castro Arajo, PhD1  ; Bruno Aragão Rocha, PhD2  ; Suzylaine da Silva Lima, MSc1  ; Thiago Buosi Silva, PhD3;  \nLaura Rabelo Leite, PhD4; Daniel Noce da Silva, MSc1  ; Maria Carolina Tostes Pintão, PhD2; Mateus Frederico de Paula, MSc3 ;  \nRejane Cristina dos Santos Silva, MSc4; Otavio Jose Eulalio Pereira, BSc2; João Vicente de Morais Malvezzi, BSc2  ; Flavia Helena da Silva, PhD2; Flvio Francisco Machado, BSc4; Keity de Moura Pinho, BSc4  ; Silvia Maria Prioli de Souza Sabino, PhD3  ;  \nLvia Loami Ruyz Jorge de Paula, PhD3 ; Jos Mendes da Silva Neto, MSc3; Karina Braga Gomes, PhD5  ; Maria das Graças Carvalho, PhD5; Vinicius Moura Ribeiro, BSc1  ; Marco Aurelio Kohara, BSc1  ; Ismael Dale Cotrim Guerreiro da Silva, PhD2,6; and  \nPedro Henrique Arajo de Souza, PhD7  \nDOI [https://doi.org/10.1200/CCI-25-00347](https://doi.org/10.1200/CCI-25-00347)  \n\n| ABSTRACT |  |\n| --- | --- |\n| PURPOSE | Recent changes in breast cancer (BC) screening guidelines have extended eligibility to women age 40-49 years, yet risk stratiﬁcation in this group remains challenging. This study evaluated the performance of a complete blood count (CBC)–based BC risk model, originally developed for women age 40-70 years, in women age 40-49 years across diverse clinical settings in Brazil. |\n| METHODS | In this retrospective multicenter study, CBC data from 239,089 women age 40-49 years were analyzed. A ridge regression model using age, neutrophilto-lymphocyte ratio (NLR), and RBC was evaluated. CBCs were stratiﬁed by timing relative to breast diagnostic procedures: same day, 1-90 days prior, and 91-180 days prior. Model performance was assessed using area under the receiver operating characteristic curve (AUC), sensitivity, and speciﬁcity, with leave-one-group-out cross-validation across ﬁve Brazilian clinical settings. |\n| RESULTS | The CBC model showed stable performance when CBCs were obtained within 3 months before diagnosis (AUC 5 0.63 6 0.03 for same day; 0.61 6 0.05 for 1- 90 days prior) . Performance declined in the 91-to 180-day interval (AUC 5 0.58 6 0.03) . NLR increased signiﬁcantly closer to diagnosis, driven mainly by neutrophilia. At 70% speciﬁcity, screening the top 30% identiﬁed 47% of cancers (relative risk 5 2. 07) . |\n| CONCLUSION | The CBC-based model provides a low-cost approach to BC risk stratiﬁcation in women age 40-49 years, particularly when CBCs are collected within 3 months of evaluation. This opportunistic strategy may be especially valuable in resource-constrained settings where routine mammographic screening is limited. |\n\nACCOMPANYING CONTENT  \n Data Supplement  \nAccepted March 11, 2026 Published April 22, 2026  \nJCO Clin Cancer Inform 10:e2500347  \n© 2026 by American Society of Clinical Oncology  \nCreative Commons Attribution Non-Commercial No Derivatives 4.0 License  \nINTRODUCTION  \nRecently, the US Preventive Services Task Force has lowered the recommended age for breast cancer (BC) screening from 50 to 40 years, aiming to improve early detection in younger women.1 However, this change has sparked controversy2,3 because of concerns about overdiagnosis, increased false positives, and the psychological and ﬁnancial burdens associated with more frequent screenings.4,5 In addition, low-and middle-income countries, which already struggle to provide consistent screening for women older than 50 years,6 may  \nface signiﬁcant difﬁculties in expanding these services to abroader, younger population.  \nIndividualized risk stratiﬁcation models have been proposed to optimize screening protocols.7 Widely used tools such as the Gail model,8 Breast Cancer Surveillance Consortium,9 and Tyrer-Cuzick model10 rely on clinical, reproductive, and imaging-related variables that are often unavailable in routine practice. Moreover, Schonberg et al11 noted a weak agreeme","cbCaihHsh5xHLszU","https://ap.wps.com/l/cbCaihHsh5xHLszU","pdf",1576677,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Context\n## Key Objective\n## Knowledge Generated\n## Relevance","[{\"question\":\"What is the study’s main objective for women aged 40–49?\",\"answer\":\"To evaluate whether routinely collected complete blood count (CBC) data can opportunistically stratify breast cancer risk in women aged 40–49, where access to systematic screening is limited.\"},{\"question\":\"How were CBC data prepared and compared across clinical timelines?\",\"answer\":\"CBCs were stratified by timing relative to breast diagnostic procedures: same day, 1–90 days prior, and 91–180 days prior, and model performance was assessed with AUC, sensitivity, and specificity.\"},{\"question\":\"What factors affected model performance as diagnosis approached?\",\"answer\":\"Discrimination was stable when CBCs were collected within 3 months of diagnosis and declined for the 91–180-day interval; the neutrophil-to-lymphocyte ratio increased closer to diagnosis, driven mainly by neutrophilia.\"}]","Multicentric Validation of a Complete Blood Count–Based Model for Breast Cancer Risk Stratification in Women Age 40-49 Years | PDF",1790094452,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad3969d23d4a0e71058c181bb36f0772.webp",983,1315,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52682ef3852fc17f4f12f8652bc0a4e4.webp",982,1314,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e1f4eeeef50689cf0cb19be6120567fa.webp",981,1312,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/968126b6d3ce01546d58d75e4cd732b8.webp",980,1311]